Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
clinical trials
4
×
life sciences
national blog main
national top stories
biotech
boston top stories
deals
new york blog main
startups
boston
cancer
fda
gene therapy
new york top stories
novartis
sanofi
abbvie
achromatopsia
adeno-associated virus
akouos
allergan
allosteric
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
atlas venture
atopic dermatitis
autoimmune disorders
beta-thalassemia
bill cassidy
biogen
bluebird bio
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
brace pharma
cancer immunotherapy
What
years
4
×
medicines
ago
deal
therapeutics
acquisitions
adding
address
adds
age
aiming
allosteric
announced
balance
bigger
biggest
bio
build
ceo
clinic
collabs
come
covid
daniel
decibel
disease
drugs
elusive
emerged
emerging
focus
forms
gave
gene
gilead
gilead’s
hearing
help
hotspot
introduce
Language
unset
Current search:
years
×
" boston blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy